Clorox vs. Merck: 49 and 15 Straight Years of Raises. Which Dividend Pays You More in 10 Years?

Chris Arnold • 6 minute read
Reviewed by: Chris Arnold
Last updated Nov 21, 2026

@Kittipong Jirasukhanont from PhonlamaiPhoto's Images via Canva, @Kittipong Jirasukhanont from PhonlamaiPhoto's Images via Canva

Key Takeaways

  • Clorox yields 4.6%, twice Merck’s 2.3%, but Merck has raised its dividend much faster over the past five years.
  • Clorox’s dividend took a risky 133% of its free cash flow over the twelve months to Sept. 30, 2026, against a well-covered 66% at Merck.
  • Clorox’s management calls its elevated payout temporary while it rebuilds its gross margin.
  • Clorox gets a new CEO in January, and Merck is preparing for Keytruda’s loss of exclusivity.

Clorox (CLX) stock rose 24% over the 10 trading days through Nov. 13, on a strong first quarter and rumors of a takeover offer. Even after that run, it yields 4.6%.

That’s twice what Merck (MRK) pays. But Merck has raised its dividend much faster: 5.8% a year from fiscal 2020 to fiscal 2025, against Clorox’s 2.0% a year from fiscal 2021 to fiscal 2026.

So if you’re putting $10,000 into one of them for income, which dividend pays you more over the next 10 years?

MetricClorox (CLX)Merck (MRK)
Dividend yield4.6%2.3%
Annual dividend$5.00 a share$3.40 a share
Dividend growth, 5 years2.0% a year (fiscal 2021-2026)5.8% a year (fiscal 2020-2025)
Cash dividend payout ratio, TTM133%66%
Net debt/EBITDA3.8x1.5x
Interest coverage6.5x5.2x

Source: TIKR; current dividends from StockAnalysis. Yields at today’s prices; TTM is the twelve months to Sept. 30, 2026.

6 safe dividend stocks paying retirees 6%+ yields

There are over 100 stocks paying 6%+ annual dividends today.

But after an extensive investment review leveraging TIKR’s proprietary data, we now believe only six of them are truly safe for retirees.

They’re all yours as part of our new investment report. Learn more about how to get access right here.

Clorox is paying out more than its free cash flow

Clorox’s first quarter of fiscal 2027, to Sept. 30, was strong on the top line. Net sales rose 33% to $1.91 billion, and adjusted EPS rose 82% to $1.55. But gross margin fell 130 basis points to 40.4% on higher costs. Management now expects about 41.5% for the full year.

That margin matters for the dividend, which Clorox pays from free cash flow. Over the twelve months to Sept. 30, 2026, its $602 million of dividends took a risky 133% of its $453 million of free cash flow. Free cash flow covered the dividend every year from fiscal 2017 to fiscal 2021, then fell short of it in three of the last five years.

Bar chart from TIKR of Clorox Company's free cash flow vs. common dividends paid, $ millions, fiscal 2017–2026 (years to June).
Clorox Company (CLX): free cash flow vs. common dividends paid, $ millions, fiscal 2017–2026 (years to June) (TIKR)

On its August call, management said “the current payout is a bit elevated, but we see this as something more transitory as we rebuild our gross margin and not something structural.” The short years of fiscal 2022 and 2024 were each followed by a covered one, but fiscal 2026’s 149% was the widest gap on the chart.

Fabian Garcia takes over as CEO on Jan. 5, 2027, and the Nov. 11 takeover rumor is unconfirmed.

At its 4.6% yield, $10,000 in Clorox pays $460 a year today. At its 2.0% pace, that grows to about $550 in year 10 (call it a 5.5% yield on your cash), and about $5,039 over the decade.

Merck has room to keep raising

Merck covers its dividend far more comfortably. Its $8.18 billion of dividends over the twelve months to Sept. 30, 2026 took a well-covered 66% of its $12.36 billion of free cash flow. Dividends ran ahead of free cash flow in fiscal 2017 and fiscal 2020, and have stayed below it every year since.

Bar chart from TIKR of Merck's free cash flow vs. common dividends paid, $ billions, fiscal 2016–2025.
Merck (MRK): free cash flow vs. common dividends paid, $ billions, fiscal 2016–2025 (TIKR)

The business behind it is still growing. Third-quarter sales rose 5% to $18.1 billion, with Keytruda up 6% to $8.6 billion and Winrevair up 93% to $694 million. Merck raised its full-year adjusted EPS outlook on Oct. 29, and CFO Caroline Litchfield said on the call, “We remain committed to the dividend with the goal of increasing it over time.” The coverage gives her room to do it.

The risk is Keytruda, nearly half of third-quarter sales, losing exclusivity. Litchfield’s view: “we see the KEYTRUDA LOE as really more of a hill on the overall revenues of our company as we will, in short order, then return to strong growth.”

$10,000 in Merck pays $230 a year today. At its 5.8% pace, that’s about $380 in year 10, a 3.8% yield on your cash, and about $2,996 over the decade.

So which dividend wins?

Clorox’s dividend pays you more over the next 10 years: about $5,039 against about $2,996 for Merck. Even at 5.8% a year, Merck’s yearly income wouldn’t pass Clorox’s until about 2046.

What decides it is the size of today’s check. Merck’s faster raises can’t make up a yield half as big in 10 years.

That’s not to knock Merck. Its dividend is far better covered, management has committed to keep raising it, and its pipeline gives it a path past Keytruda. Over this 10-year period, though, Clorox’s head start is too big, as long as its payout falls back under its free cash flow the way it has after past short years.

If Clorox can’t rebuild its gross margin toward the 41.5% management expects, a cut would change this answer.

Forget Clorox: 6 safe 6%+ dividend yields you can buy right now

Dividends can hold the key to enormous wealth. But only if you buy the right ones.

Picking the right high-yield dividend stock can be the difference between a dream retirement…and scraping by every month, waiting for the next Social Security check to clear.

We’ve identified six stocks yielding 6%+ that we believe every retiree should know about right now. (And Clorox isn’t one of them.)

Learn more here.

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any of the stocks mentioned. Thank you for reading, and happy investing!

Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.

Sign Up for FREENo credit card required